Platinum Sponsors
Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
AstraZeneca
AstraZeneca has a deep-rooted heritage in oncology and offers a quickly growing portfolio of medicines with the potential to transform patients' lives. By following the science and championing the development of personalised combinations, AstraZeneca is working to redefine cancer treatment and one day eliminate cancer as a cause of death.
Janssen EMEA
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.
Gold Sponsors
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular and neuroscience. Our employees work every day to transform patients’ lives through science.
MSD
For more than 125 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals.
Silver Sponsors
Lilly
About Eli Lilly and Company: Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission.
Pfizer Oncology
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.
Bronze Sponsors
Novartis Oncology
Novartis is reimagining medicine to improve people’s lives. We use innovative science and digital technologies to create transformative treatments. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our medicines. About 109,000 people of more than 145 nationalities work at Novartis.
Takeda
Takeda is a patient-focused, innovation-driven global pharmaceutical. Our mission is to strive towards better health and a brighter future for people worldwide through leading innovation in medicine. Takeda’s Global Oncology Business Unit endeavors to deliver novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion for improving the lives of patients.
Sponsors
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated.
Molecular Health
Since 2004, Molecular Health stands for transforming big clinical data into improved treatment decisions. Using our cloud based Dataome technology platform, we analyze molecular and clinical data of individual patients and compare it to the world’s most up-to-date comprehensive medical, biological, and pharmacological knowledge. Our MH Guide software product family enables physicians to take the most informed treatment decisions.
Sanofi Genzyme Regeneron Alliance
Regeneron and Sanofi have collaborated since 2007 to develop fully-human monoclonal antibodies for the treatment of serious diseases, including cancer. Together, they are committed to advancing therapies that make a difference for patients.